Jaxwest8: Assessment of novel compounds (L-DOPA) to inhibit the onset and progression of Parkinsonian pathology in an acute model of Parkinson's Disease using C57BL/6J male mice (2009)
Jackson Laboratory Yan Yang With: Yang Y, Rodriguez T
Jaxwest8 downloads
Click on "Download" link or button below, to see the available downloads for this project.
Click on "Download" link or button below, to see the available downloads for this project.
| Institutional authorship |
Jackson Laboratory
|
| Investigators |
Yan Yang The Jackson Laboratory, Bar Harbor, ME |
| Participants | Yang Y, Rodriguez T |
| Contact | Yan Yang yan.yang@jax.org
|
| Affiliated Center | JAX In Vivo Services |
| One-strain study | |
| MPD identifiers | Jaxwest8 MPD:328 |
| No updates/corrections. Initial release date: 06/2009. | |
|
Click above to copy-paste the entire citation for this MPD web page. |
Purpose: The objective of this study was to assess the therapeutic potential of a novel compound (L-DOPA) to inhibit the onset and progression of cell loss and development of Parkinsonian pathology in an acute model of MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) induced Parkinson Disease using using 9-wk-old C57BL/6J male mice.
By posting this data, JAX® In Vivo Services contributes to community research resources and fulfills an agreement with clients to make normative data public.
Investigator's notes and website:
Compound evaluation services: Chronic MPTP Model of Parkinson’s Disease
Available download:
Data: Jaxwest8.xls
